AbbVie wants to see shared decision making widely adopted across NHS services.
To support this ambition, throughout 2020 AbbVie worked to highlight the importance of shared decision making. In Spring, we held the Shared Decision Making Showcase in Parliament. A year on from the publication of NHS England’s NHS Long Term Plan, and Universalised Personalised Care Plan – which established ambitious targets to put SDM at the heart of patient care – the showcase provided a platform for patient groups, NHS Trusts, and healthcare providers to share their innovative work.
The projects at the Showcase ranged from MS, arthritis, Lymphoma, Autism, Hepatitis C, kidney dialysis and more — all focused on empowering patients to take an active part in decisions about their treatment and care.
As the year and the COVID-19 pandemic progressed, we wanted to delve into how the virus has impacted patients, healthcare professionals and the entire NHS system. In Autumn 2020, we held two virtual discussions with patient advocacy groups, national and professional bodies and key stakeholders to understand how the pandemic has impacted SDM, as well as the longer term changes needed to improve patient involvement in their treatment and care decisions as a whole.
These discussions brought to light both the existing challenges and new opportunities to redesign and reshape our NHS to embed SDM as best practice.